Kronox Lab Sciences Ltd
Kronox Lab Sciences Ltd is a specialty chemicals company that provides chemical products and services, primarily generating revenue through the sale of chemical compounds and related solutions.
Business. Kronox Lab Sciences Ltd (KROO.NS) is a specialty chemicals company headquartered in India. The firm operates within the Basic Materials sector, focusing on the production and sale of chemical products. It is primarily listed on the National Stock Exchange of India. Specific details regarding operating segments or geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Kronox Lab Sciences Ltd (KROO.NS) is a specialty chemicals company headquartered in India. The firm operates within the Basic Materials sector, focusing on the production and sale of chemical products. It is primarily listed on the National Stock Exchange of India. Specific details regarding operating segments or geographic revenue breakdowns are not available.
Kronox Lab Sciences Ltd maintains a strong capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a conservative leverage profile. The company's liquidity is robust, as evidenced by a current ratio of 7.28, which is significantly higher than the industry median for specialty chemicals firms. This liquidity position is supported by strong operating cash flow of INR 306.97 million and free cash flow of INR 218.91 million.
Profitability metrics for Kronox Lab Sciences Ltd are strong, with a return on equity (ROE) of 28.26% and a return on assets (ROA) of 25.77%. These figures exceed the industry median for ROE and ROA in the specialty chemicals sector, indicating efficient use of equity and assets to generate returns. The company's operating margin is 31.7%, which is in line with the industry's preferred profitability metrics.
The company's revenue is concentrated in a single business segment, as disclosed in its latest financial filing, with no geographic diversification provided in the available data. This lack of segment or geographic diversification may expose the company to higher concentration risk, particularly in volatile markets or during supply chain disruptions.
Kronox Lab Sciences Ltd is on a growth trajectory, with a capital expenditure of INR -31.04 million in the latest period, suggesting a focus on maintaining rather than expanding operations. The company's outlook for the current fiscal year is positive, with a projected increase in revenue and operating income, although specific numeric deltas are not disclosed in the available data.
Risk factors for the company are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's dilution potential is also low, as there is no indication of recent or planned share issuances that could dilute existing shareholders. The absence of long-term debt and the strong equity position further reduce financial risk.
Recent events for Kronox Lab Sciences Ltd include the filing of its latest financial results, which show strong performance across key financial metrics. No significant regulatory or legal events were disclosed in the available data, and the company has not issued any recent press releases or transcripts that would indicate material changes in its business operations.
- Strong capital structure with no long-term debt and a high current ratio.
- High profitability with ROE and ROA well above industry medians.
- Revenue and operating income are expected to grow in the current fiscal year.
- Low liquidity and dilution risk based on current filings and financials.
- Revenue concentration in a single segment may increase exposure to market volatility.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- Kronox Lab Sciences Ltd Market data — financials · 2026-05-28